Hofseth BioCare ASA is a company specializing in the development and supply of premium, marine-derived ingredients for various applications in both human and animal health. Its market presence extends from Norway to an international scale. The company offers a diverse array of products. These include its general Brilliant salmon oil, alongside specialized formulations like OmeGo salmon oil, which is designed to support healthy cholesterol levels and cardiovascular function. ProGo, a rapidly absorbing salmon protein hydrolysate powder, serves as an efficient protein supplement. For bone and joint support, CalGo is a marine calcium powder developed to bolster cartilage function and promote overall joint health. Addressing beauty and wellness needs, CollaGo is a collagen peptide powder aimed at enhancing the strength and appearance of hair, skin, and nails. Rounding out their offerings is PetGo, a non-soluble protein for animal applications. Hofseth BioCare employs a multi-faceted distribution strategy, reaching customers through a network of independent distributors, agents, and its dedicated internal sales team. Furthermore, the firm maintains a significant research collaboration with the Stanford University School of Medicine. This partnership involves jointly conducting pre-clinical and clinical studies focused on conditions such as necrotizing enterocolitis and irritable bowel syndrome. Established in 2000, Hofseth BioCare ASA maintains its corporate headquarters in Ålesund, Norway.
—
Hofseth BioCare ASA is a company specializing in the development and supply of premium, marine-derived ingredients for various applications in both human and animal health. Its market presence extends from Norway to an international scale. The company offers a diverse array of products. These include its general Brilliant salmon oil, alongside specialized formulations like OmeGo salmon oil, which is designed to support healthy cholesterol levels and cardiovascular function. ProGo, a rapidly absorbing salmon protein hydrolysate powder, serves as an efficient protein supplement. For bone and joint support, CalGo is a marine calcium powder developed to bolster cartilage function and promote overall joint health. Addressing beauty and wellness needs, CollaGo is a collagen peptide powder aimed at enhancing the strength and appearance of hair, skin, and nails. Rounding out their offerings is PetGo, a non-soluble protein for animal applications. Hofseth BioCare employs a multi-faceted distribution strategy, reaching customers through a network of independent distributors, agents, and its dedicated internal sales team. Furthermore, the firm maintains a significant research collaboration with the Stanford University School of Medicine. This partnership involves jointly conducting pre-clinical and clinical studies focused on conditions such as necrotizing enterocolitis and irritable bowel syndrome. Established in 2000, Hofseth BioCare ASA maintains its corporate headquarters in Ålesund, Norway.
—
Daily adjusted close
Hofseth BioCare ASA is a company specializing in the development and supply of premium, marine-derived ingredients for various applications in both human and animal health. Its market presence extends from Norway to an international scale. The company offers a diverse array of products. These include its general Brilliant salmon oil, alongside specialized formulations like OmeGo salmon oil, which is designed to support healthy cholesterol levels and cardiovascular function. ProGo, a rapidly absorbing salmon protein hydrolysate powder, serves as an efficient protein supplement. For bone and joint support, CalGo is a marine calcium powder developed to bolster cartilage function and promote overall joint health. Addressing beauty and wellness needs, CollaGo is a collagen peptide powder aimed at enhancing the strength and appearance of hair, skin, and nails. Rounding out their offerings is PetGo, a non-soluble protein for animal applications. Hofseth BioCare employs a multi-faceted distribution strategy, reaching customers through a network of independent distributors, agents, and its dedicated internal sales team. Furthermore, the firm maintains a significant research collaboration with the Stanford University School of Medicine. This partnership involves jointly conducting pre-clinical and clinical studies focused on conditions such as necrotizing enterocolitis and irritable bowel syndrome. Established in 2000, Hofseth BioCare ASA maintains its corporate headquarters in Ålesund, Norway.